The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Hypertenion: Sensitivity of Patient Outcomes to Pharmacist Interventions. Part II: Systematic Review and Meta-Analysis in Hypertension Management
Abstract
Background: Hypertension is a major health concern worldwide due to its deleterio us impact. Few studies have quantitatively assessed pharmacists’ interventions in hypertensive patients. Objectives: To identify and quantify outcomes sensitive to pharmacists’ interventions. Methods: International Pharmaceutical Abstracts, MEDLINE, Cochrane Central, and EMBASE were searched from inception through December 2006. Two independent reviewers identified articles; results were compared and resolved through consensus. Data extracted included intervention type, patient numbers, demographics, study characteristics, instruments used, data compared, and outcomes reported. A random effects meta-analysis was used to combine data. Study quality was assessed using the Downs–Black scale. Results: Of 203 potential articles identified, 98 were selected and their abstracts were read. Nine of these were reviewed full-text and 19 more were identified from references, resulting in a total of 28 articles. Research designs included 18 randomized controlled trials, 6 single-arm clinical trials, 3 nonrandomized comparative trials, and 1 database study. Average quality score was 66% ± 12% (fair). Medication management (82%) and hypertension education (68%) were the interventions most used. Thirty-nine study results (57% of all outcomes evaluated) were sensitive to pharmacists’ interventions. Meta-analysis of 2246 patients in 13 studies found that pharmacists’ interventions significantly reduced systolic blood pressure (10.7 ± 11.6 mm Hg; p = 0.002), while controls remained unchanged (3.2 ± 12.1 mm Hg; p = 0.361). Pharmacists’ interventions further reduced systolic blood pressure (6.9 ± 12.1 mm Hg;p = 0.047) over controls. Nonsensitive results included further reduction in diastolic blood pressure (3.6 ± 3.7 mm Hg; p = 0.06), quality of life (1 of 8 significant), and adherence (5 of 13 significant). Conclusions: Systolic blood pressure is sensitive to pharmacists’ interventions. Other outcomes may also be sensitive; however, more high-quality studies are needed for a comprehensive quantitative assessment
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Opportunities and responsibilities in pharmaceutical care
Hepler, C. D., & Strand, L. M. (1990) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/47.3.533 · Cited by 2,895
Amos, A. F., McCarty, D. J., & Zimmet, P. (1997) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199712)14:5+<s7::aid-dia522>3.0.co;2-r · Cited by 1,882
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Cranor, C. W., Bunting, B. A., & Christensen, D. B. (2003) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658003321480713 · Cited by 728
IMPROVEMENT OF MEDICATION COMPLIANCE IN UNCONTROLLED HYPERTENSION
Haynes, R. B., Gibson, E., Hackett, B., Sackett, D., Taylor, D. W., Roberts, R., & Johnson, A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91737-2 · Cited by 513
A systematic review of interventions to improve diabetes care in socially disadvantaged populations
Glazier, R. H., Bajcar, J., Kennie, N. R., & Willson, K. (2006) · Diabetes Care · doi:10.2337/dc05-1942 · Cited by 385
Self-citationPharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care
Krska, J. (2001) · Age and Ageing · doi:10.1093/ageing/30.3.205 · Cited by 359
Sadur, C. N., Moline, N., Costa, M., Michalik, D., Mendlowitz, D., Roller, S., Watson, R., Swain, B. E., Selby, J. V., & Javorski, W. C. (1999) · Diabetes Care · doi:10.2337/diacare.22.12.2011 · Cited by 349
Antidepressant-Induced Sexual Dysfunction
Gregorian, R. S., Golden, K. A., Bahce, A., Goodman, C., Kwong, W. J., & Khan, Z. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a195 · Cited by 320
Evaluation of a Pharmaceutical Care Model on Diabetes Management
Jaber, L. A., Halapy, H., Fernet, M., Tummalapalli, S., & Diwakaran, H. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000305 · Cited by 313
Tsuyuki, R. T. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1149 · Cited by 290
Rothman, R. L., Malone, R., Bryant, B., Shintani, A. K., Crigler, B., Dewalt, D. A., Dittus, R. S., Weinberger, M., & Pignone, M. P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.09.017 · Cited by 267
Pharmaceutical Care Services and Results in Project ImPACT: Hyperlipidemia
Bluml, B. M., McKenney, J. M., & Cziraky, M. J. (2000) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31059-2 · Cited by 258
Choe, H. M., Mitrovich, S., Dubay, D., Hayward, R. A., Krein, S. L., & Vijan, S. S. (2005) · PubMed · Cited by 215
Apparent discontinuation rates in patients prescribed lipid‐lowering drugs
Simons, L. A., Levis, G., & Simons, J. (1996) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1996.tb94138.x · Cited by 214
Physician‐Pharmacist Comanagement of Hypertension: A Randomized, Comparative Trial
Borenstein, J. E., Graber, G., Saltiel, E., Wallace, J., Ryu, S., Jackson, A., Deutsch, S., & Weingarten, S. R. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.2.209.32096 · Cited by 200
Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic
Vivian, E. M. (2002) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.17.1533.34127 · Cited by 193
Patient Self-Management Program for Diabetes: First-Year Clinical, Humanistic, and Economic Outcomes
Garrett, D. G., & Bluml, B. M. (2005) · Journal of the American Pharmacists Association · doi:10.1331/1544345053623492 · Cited by 190
Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes
Clifford, R. M., Davis, W. A., Batty, K. T., & Davis, T. M. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.771 · Cited by 188
Management of Patients with Type 2 Diabetes by Pharmacists in Primary Care Clinics
Coast-Senior, E. A., Kroner, B. A., Kelley, C. L., & Trilli, L. E. (1998) · Annals of Pharmacotherapy · doi:10.1345/aph.17095 · Cited by 188
Mehos, B. M., Saseen, J. J., & MacLaughlin, E. J. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.17.1384.34891 · Cited by 183
Wijk, B. L. V., Klungel, O. H., Heerdink, E. R., & de Boer, A. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e027 · Cited by 162
Comprehensive Pharmaceutical Care in the Chain Setting
Park, J. J., Kelly, P. J., Carter, B. L., & Burgess, P. P. (1996) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30099-7 · Cited by 155
Pharmacist Intervention Program for Control of Hypertension
Chabot, I., Moisan, J., Grégoire, J., & Milot, A. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c267 · Cited by 154
Solomon, D. K., Portner, T. S., Bass, G. E., Gourley, D. R., Gourley, G. A., Holt, J. M., Wicke, W. R., Braden, R. L., Eberle, T. N., Self, T. H., et al. (1998) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30371-0 · Cited by 147
Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension
Bogden, P. E., Abbott, R. D., Williamson, P., Onopa, J., & Koontz, L. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00225.x · Cited by 143
Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)
Zillich, A. J., Sutherland, J. M., Kumbera, P. A., & Carter, B. L. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0226.x · Cited by 142
Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes
Sookaneknun, P., Richards, R. M., Sanguansermsri, J., & Teerasut, C. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d605 · Cited by 141
Ellis, S. L., Carter, B. L., Malone, D. C., Billups, S. J., Okano, G. J., Valuck, R. J., Barnette, D. J., Sintek, C. D., Covey, D. F., Mason, B. J., et al. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.19.1508.34852 · Cited by 139
The Relationship Between Literacy and Glycemic Control in a Diabetes Disease-Management Program
Rothman, R. L., Malone, R., Shilliday, B. B., Horlen, C. K., DeWalt, D. A., & Pignone, M. P. (2004) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572170403000219 · Cited by 136
Murray, M. D., Harris, L. E., Overhage, J. M., Zhou, X., Eckert, G. J., Smith, F. E., Buchanan, N. N., Wolinsky, F. D., McDonald, C. J., & Tierney, W. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.4.324.33173 · Cited by 131
Caring for Poorly Controlled Diabetes Mellitus: A Randomized Pharmacist Intervention
Odegard, P. S., Goo, A., Hummel, J., Williams, K. L., & Gray, S. L. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e438 · Cited by 128
Improving primary care in rural Alabama with a pharmacy initiative
Taylor, C. T., Byrd, D. C., & Krueger, K. P. (2003) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/60.11.1123 · Cited by 123
Pharmacists' Ability to Influence Outcomes of Hypertension Therapy
Erickson, S. R., Slaughter, R. L., & Halapy, H. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03687.x · Cited by 123
Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting
Munroe, W. (1997) · Clinical Therapeutics · doi:10.1016/s0149-2918(97)80078-1 · Cited by 122
Kiel, P. J., & McCord, A. D. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g356 · Cited by 121
Effect of a Pharmacist-Managed Diabetes Care Program in a Free Medical Clinic
Davidson, M. B., Karlan, V. J., & Hair, T. L. (2000) · American Journal of Medical Quality · doi:10.1177/106286060001500403 · Cited by 110
Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic
Okamoto, M. P., & Nakahiro, R. K. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.17.1337.34424 · Cited by 110
Experience-based group education in Type 2 diabetes
Sarkadi, A., & Rosenqvist, U. (2004) · Patient Education and Counseling · doi:10.1016/j.pec.2003.10.009 · Cited by 109
Outcomes of a Community Pharmacy-Based Diabetes Monitoring Program
Berringer, R., Shibley, M. C. H., Cary, C. C., Pugh, C. B., Powers, P. A. G., & Rafi, J. A. (1999) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(15)30369-7 · Cited by 107
Malone, D. C., Carter, B. L., Billups, S. J., Valuck, R. J., Barnette, D. J., Sintek, C. D., Okano, G. J., Ellis, S. L., Covey, D. F., Mason, B. J., et al. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.15.1149.34590 · Cited by 96
Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients
Hawkins, D., Fiedler, F. P., Douglas, H. L., & Eschbach, R. C. (1979) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/36.10.1321 · Cited by 96
Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in Rural Portugal
Garçao, J. A., & Cabrita, J. (2002) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658002762063691 · Cited by 91
Reducing Low-Density Lipoprotein Cholesterol Levels in an Ambulatory Care System
Shaffer, J. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.21.2330 · Cited by 91
Critical Analysis of the Pharmaceutical Care Research Literature
Kennie‐Kaulbach, N., Schuster, B. G., & Einarson, T. R. (1998) · Annals of Pharmacotherapy · doi:10.1177/106002809803200101 · Cited by 88
Self-citationBozovich, M., Rubino, C. M., & Edmunds, J. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.17.1375.34895 · Cited by 86
Vrijens, B., Belmans, A., Matthys, K. E., de Klerk, E., & Lesaffre, E. M. E. H. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1198 · Cited by 85
Effectiveness of Pharmacist‐Administered Diabetes Mellitus Education and Management Services
Ragucci, K. R., Fermo, J. D., Wessell, A. M., & Chumney, E. C. G. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.2005.25.12.1809 · Cited by 84
Wermeille, J. P., Bennie, M., Brown, I., & McKnight, J. (2004) · Pharmacy World & Science · doi:10.1023/b:phar.0000013465.24857.a8 · Cited by 84
DeCastro, M. L., Fuchs, F. D., COSTASANTOS, M., Maximiliano, P., Gus, M., BELTRAMIMOREIRA, L., & Ferreira, M. B. C. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.11.009 · Cited by 82
Irons, B. K., Lenz, R. J., Anderson, S. L., Wharton, B. L., Habeger, B., & Anderson, H. G. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.15.1294.33476 · Cited by 81
Part 3. Humanistic Outcomes in the Hypertension and COPD Arms of a Multicenter Outcomes Study
Gourley, G. A., Portner, T. S., Gourley, D. R., Rigolosi, E. L. M., Holt, J. M., Solomon, D. K., Bass, G. E., Wicke, W. R., & Braden, R. L. (1998) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30372-2 · Cited by 80
Clinical Impact of a Pharmacist‐Managed Diabetes Mellitus Drug Therapy Management Service
McCord, A. D. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.2.248 · Cited by 80
Blenkinsopp, A., Phelan, M. J., Bourne, J., & Dakhill, N. (2000) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2000.tb01002.x · Cited by 78
Implementation and Evaluation of Australian Pharmacists’ Diabetes Care Services
Armour, C. L., Taylor, S. J., Hourihan, F., Smith, C., & Krass, I. (2004) · Journal of the American Pharmacists Association · doi:10.1331/1544345041475625 · Cited by 75
Impact of pharmacist-conducted home visits on the outcomes of lipid-lowering drug therapy
Peterson, G. M., Fitzmaurice, K. D., Naunton, M., Vial, J. H., Stewart, K., & Krum, H. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00532.x · Cited by 74
Scott, M. K., Widmer, L. B., Stacey, S., & Popovich, N. G. (1995) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179502100207 · Cited by 69
Rothman, R. L., Malone, R., Shilliday, B. B., Horlen, C. K., & Pignone, M. P. (2003) · American Journal of Medical Quality · doi:10.1177/106286060301800202 · Cited by 68
Hatoum, H. T., & Akhras, K. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700917 · Cited by 68
Impact on Medication Use and Adherence of Australian Pharmacists’ Diabetes Care Services
Krass, I., Taylor, S. J., Smith, C., & Armour, C. L. (2005) · Journal of the American Pharmacists Association · doi:10.1331/1544345052843093 · Cited by 67
Diwan, V. K. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00221-b · Cited by 64
Glycosylated Hemoglobin, Cardiovascular, and Renal Outcomes in a Pharmacist-Managed Clinic
Cioffi, S. T., Caron, M. F., Kalus, J. S., Hill, P. G., & Buckley, T. E. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d359 · Cited by 63
Development and clinical outcomes of pharmacist-managed diabetes care clinics
Morello, C. M., Zadvorny, E. B., Cording, M. A., Suemoto, R. T., Skog, J., & Harari, A. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp050430 · Cited by 63
Suppapitiporn, S., Chindavijak, B., & Onsanit, S. (2005) · PubMed · Cited by 62
Self-Efficacy Theory as a Framework for Community Pharmacy-Based Diabetes Education Programs
Johnson, J. A. (1996) · The Science of Diabetes Self-Management and Care · doi:10.1177/014572179602200307 · Cited by 60
Lalonde, L., O'Connor, A. M. C., Drake, E. R., Duguay, P., Lowensteyn, I., & Grover, S. A. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.9.909.36104 · Cited by 58
Implementation of a Pharmacist-Led Clinic for Hypertensive Patients in Primary Care – A Pilot Study
Reid, F., Murray, P., & Storrie, M. (2005) · Pharmacy World & Science · doi:10.1007/s11096-004-2563-y · Cited by 54
Geber, J. M., Parra, D., Beckey, N. P., & Korman, L. B. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.738.34061 · Cited by 54
Clifford, R. M., Batty, K. T., Davis, T. M. E., Davis, W. A., Stein, G. R., Stewart, G. O., & Plumridge, R. J. (2002) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2002.tb00592.x · Cited by 52
A Randomized Trial Comparing Intensive and Passive Education in Patients With Diabetes Mellitus
Raji, A., Gomes, H. E., Beard, J. O., MacDonald, P., & Conlin, P. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.11.1301 · Cited by 52
Shane‐McWhorter, L., & Oderda, G. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.1.96.55623 · Cited by 50
Positive benefits of a pharmacist-managed hypertension clinic in Nigeria
Erhun, W. O., Agbani, E. O., & Bolaji, E. E. (2005) · Public Health · doi:10.1016/j.puhe.2004.11.009 · Cited by 46
A multifaceted intervention in support of diabetes treatment guidelines: a cont trial
Hirsch, I. B., Goldberg, H. I., Ellsworth, A. J., Evans, T. C., Herter, C. D., Ramsey, S. D., Mullen, M. C., Neighbor, W. E., & Cheadle, A. D. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00100-6 · Cited by 46
Academic detailing improves identification and reporting of adverse drug events.
Schlienger, R. G., Lüscher, T. F., Haefeli, W. E., & Schoenenberger, R. A. (1999) · Pharmacy World & Science · doi:10.1023/a:1008631926100 · Cited by 45
Hennessy, S., Leonard, C. E., Yang, W. P., Kimmel, S. E., Townsend, R. R., Wasserstein, A. G., Have, T. R. T., & Bilker, W. B. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.9.1342 · Cited by 41
Achieving Cholesterol Target in a Managed Care Organization (ACTION) Trial
Straka, R. J., Taheri, R., Cooper, S. L., & Smith, J. C. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.3.360.59294 · Cited by 40
Yamada, C., Johnson, J. A., Robertson, P., Pearson, G. J., & Tsuyuki, R. T. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.1.110.55619 · Cited by 40
Charrois, T. L., Durec, T., & Tsuyuki, R. T. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l302 · Cited by 39
Tett, S. E., Higgins, G. M., & Armour, C. L. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700118 · Cited by 34
Simpson, S. H., Johnson, J. A., Biggs, R. S., & Tsuyuki, R. T. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.4.389.33169 · Cited by 32
Lee, S. S. C., Cheung, P. P., & Chow, M. S. S. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004265364 · Cited by 32
Goal attainment and maintenance of serum cholesterol level in a pharmacist-coordinated lipid clinic
O'Donnell, D. C., Chen, N. T.-W., & Piziak, V. K. (2001) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/58.4.325 · Cited by 32
Effect of a clinical pharmacy service on lipid control in patients with peripheral arterial disease
Rehring, T. F., Stolcpart, R. S., Sandhoff, B. G., Merenich, J. A., & Hollis, H. W. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.019 · Cited by 26
Konzem, S. L., Gray, D. R., & Kashyap, M. L. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03068.x · Cited by 23
Taylor, S. J., Milanova, T. F., Hourihan, F., Krass, I., Coleman, C., & Armour, C. L. (2005) · International Journal of Pharmacy Practice · doi:10.1211/0022357055290 · Cited by 23
Cheng, C. W. R., Woo, K.-S., Chan, J. C. N., Tomlinson, B., & You, J. H. S. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.4.411 · Cited by 21
Shojania, K. G., Ranji, S. R., McDonald, K. M., Grimshaw, J. M., Sundaram, V., Rushakoff, R. J., & Owens, D. K. (2006) · JAMA · doi:10.1001/jama.296.4.427 · Cited by 20
Gong, C. (1999) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.1999.5.6.511 · Cited by 17
Cost of a Pharmacist‐Directed Intervention to Increase Treatment of Hypercholesterolemia
Hilleman, D. E., Faulkner, M. A., & Monaghan, M. S. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.11.1077.36145 · Cited by 15
Wahlström, R., Tomson, G. B., Diwan, V. K., Beermann, B. A., & Sterky, G. (1995) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2630040203 · Cited by 14
Clinical Outcomes Associated with Pharmacist Involvement in Patients with Dyslipidemia: A Review
Cross, L. B., & Franks, A. S. (2005) · Disease Management & Health Outcomes · doi:10.2165/00115677-200513010-00004 · Cited by 11
Pharmaceutical Care Services for Patients with Hypertension
Carter, B. L., & Zillich, A. J. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d094 · Cited by 11
Graham, M. R., Landgraf, C. G., & Lindsey, C. C. (2003) · Journal of Pharmacy Technology · doi:10.1177/875512250301900601 · Cited by 7
Role of the Pharmacist in the Management of Dyslipidemia
Olson, K. L., & Potts, L. A. (2006) · Journal of Pharmacy Practice · doi:10.1177/0897190006290046 · Cited by 6
Shintoh, M., Iwakawa, S., Shimada, Y., Fujita, M., Sugahara, K., & KONISHI, K. (2001) · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · doi:10.5649/jjphcs.27.337 · Cited by 5
Alldred, D. P., Booth, C. M., & Chrystyn, H. (2001) · International Journal of Pharmacy Practice · doi:10.1111/j.2042-7174.2001.tb01059.x · Cited by 3
Research works printed but not linked: 17
- Strand L. Re-visioning the profession. J Am Pharm Assoc 1997; 37: 474-8.
- 10.1016/S1086-5802(16)31061-0 · doi:10.1016/s1086-5802(16)31061-0
- Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol 2003; 19: 391-6.
- 10.1097/00005650-200102000-00002 · doi:10.1097/00005650-200102000-00002
- 10.1001/jama.1975.03260030032016 · doi:10.1001/jama.1975.03260030032016
- 10.1097/00005650-198102000-00002 · doi:10.1097/00005650-198102000-00002
- Gonzales ME, Thompson ST, Vilme MC, . Design, implementation, and impact of a pharmacist-managed hypertension clinic: an 8-month evaluation (abstract). Pharmacotherapy 2004; 24:1426.
- 10.1093/milmed/165.2.106 · doi:10.1093/milmed/165.2.106
- 10.1111/j.1365-2710.2005.00663.x · DOI
- 10.1093/ajhp/60.6.554 · doi:10.1093/ajhp/60.6.554
- 10.1592/phco.26.9.1333 · doi:10.1592/phco.26.9.1333
- McKenney JM, Brown ED, Necsary R, Reavis HL. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract 1978; 1: 50-6.
- McKenney JM, Witherspoon JM. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hosp Pharm 1985; 20: 408-15.
- Menard PJ, Kirshner BS, Kloth DD, Pyka RS, Hill LR, Venkataraman K. Management of the hypertensive patient by the pharmacist prescriber. Hosp Pharm 1986; 21: 20-34.
- Morse GD, Douglas JH, Stewart R, Gal P. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm 1986; 43: 905-9.
- 10.1592/phco.20.3.119.34778 · doi:10.1592/phco.20.3.119.34778
- 10.1023/A:1012227018705 · doi:10.1023/a:1012227018705
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses
Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin, J. R., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181e57962 · Cited by 809
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2014) · Blood Pressure · doi:10.3109/08037051.2014.868629 · Cited by 739
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
Metadata
- Authors
- Machado, M., Bajcar, J., Guzzo, G. C., & Einarson, T. R.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2007-11
- Volume
- 41
- Issue
- 11
- Pages
- 1770-1781
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2123895995
- Cited by
- 378
- References
- 104
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.